Caeli Nova signs agreement with Airbus

Breathing technology expert Caeli Nova and Airbus are to collaborate on Cordillera, Caeli Nova’s new passenger emergency oxygen system, for use onboard Airbus aircraft, following the signing of a Co-Development Partnership Agreement.

Cordillera uses Caeli Nova’s patented technology to improve passenger oxygenation in the rare event of an emergency decompression. Cordillera extends the performance of existing oxygen systems by enabling the aircraft to safely divert at a higher altitude, therefore allowing airlines to operate the most direct air routes, often over high terrain, reducing flight times, fuel usage and carbon emissions.

Tim Wakeford, CEO at Caeli Nova said: “Over the past three years we have built a team that is able to adapt quickly and operate highly collaboratively to drive innovation forward. For example, in December 2020 we received initial Design Organisation approval from EASA following an intensive fourteen-month process, an achievement that can take companies significantly longer. We will be bringing this agile approach to our work with Airbus and look forward to seeing the results.”